Summit Therapeutics
SMMT
#2225
Rank
โ‚ฌ7.65 B
Marketcap
9,57ย โ‚ฌ
Share price
-1.59%
Change (1 day)
-34.10%
Change (1 year)

Earnings for Summit Therapeutics (SMMT)

Earnings in 2026 (TTM): -โ‚ฌ0.73 Billion

According to Summit Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ0.99 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Summit Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.73 Billion-26.47%
2025 -โ‚ฌ0.99 Billion387.84%
2024 -โ‚ฌ0.21 Billion-64.01%
2023 -โ‚ฌ0.57 Billion680.54%
2022 -โ‚ฌ71.78 Million-11.08%
2021 -โ‚ฌ80.72 Million67.46%
2020 -โ‚ฌ48.21 Million29.71%
2019 -โ‚ฌ37.16 Million
2014 -โ‚ฌ29.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-โ‚ฌ0.12 Billion-84.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-โ‚ฌ2.06 Million-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
-โ‚ฌ0.14 Billion-81.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-โ‚ฌ0.58 Billion-24.71%๐Ÿ‡บ๐Ÿ‡ธ USA